New findings on how past viral respiratory infections affect future, unrelated ones could lead to therapies for boosting general antiviral immunity—and potentially better pandemic preparedness.
It may be the most baffling quirk of COVID: What manifests as minor, flu-like symptoms in some individuals spirals into severe disease, disability, and even death in others.
Most antibiotics are double-edged swords. Besides killing the pathogen they are prescribed for, they also decimate beneficial bacteria and change the composition of the gut microbiome.
Scientists have long searched in vain for a class of brain cells that could explain the visceral flash of recognition that we feel when we see a very familiar face, like that of our grandmothers.
oanne Chory, who pioneered the application of molecular genetics to plant biology and transformed our understanding of photosynthesis, will receive the 2020 Pearl Meister Greengard Prize, the preeminent international award recognizing outstanding women scientists.
The Rockefeller University has announced that Xiaowei Zhuang, inventor of novel molecular-imaging techniques, will be awarded the 2019 Pearl Meister Greengard Prize, the preeminent international award for women in biomedical science. Zhuang is the David B. Arnold Professor of Science at Harvard University, and a Howard Hughes Medical Institute investigator. She will receive the prize on November 19 at a ceremony at Rockefeller hosted by the architect Billie Tsien.
The Rockefeller University has announced that Jennifer Doudna will receive this year's Pearl Meister Greengard Prize, a major international accolade honoring outstanding women scientists.
This year’s Albert Lasker Award for Basic Medical Research, the most prestigious American prize in science, honors Rockefeller University’s Jeffrey M. Friedman, who discovered leptin, a hormone that regulates food intake and body weight.
The Rockefeller University announced today that its Board of Trustees has elected Marc Tessier-Lavigne, Ph.D., a leader in the study of brain development and currently Genentech executive vice president for research and chief scientific officer, as the 10th president of the university.
Scientists have discovered how the cancer drug Gleevec attacks beta-amyloid, the primary component of senile plaques in Alzheimer's disease. The finding suggests that drugs modeled on Gleevec could provide new treatments for this disease.
Two compounds emitted by mosquito predators that make the mosquitoes less inclined to lay eggs in pools of water may provide new environmentally friendly tactics for repelling and controlling disease-carrying insects.